Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

Nature Communications

Volumn 2, Issue 1, 2011, Pages

  Balaj, Leonora ^a,b   Lessard, Ryan ^a   Dai, Lixin ^c   Cho, Yoon Jae ^d   Pomeroy, Scott L ^a,d   Breakefield, Xandra O ^a   Skog, Johan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE AMPLIFICATION; GENE SEQUENCE; HORIZONTAL GENE TRANSFER; HUMAN; MOUSE; NONHUMAN; ONCOGENE C MYC; RETROPOSON; RNA TRANSCRIPTION; TRANSPOSON; AGAR GEL ELECTROPHORESIS; ANIMAL; CYTOLOGY; ENDOTHELIUM CELL; GENE DOSAGE; GENETICS; METABOLISM; NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY VESICLE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE; UMBILICAL VEIN;

HUMAN ENDOGENOUS RETROVIRUSES; MUS;

COMPLEMENTARY DNA; MYC PROTEIN; RNA PRECURSOR;

ANIMALS; CELL LINE, TUMOR; DNA, COMPLEMENTARY; ELECTROPHORESIS, AGAR GEL; ENDOTHELIAL CELLS; GENE DOSAGE; HUMANS; MICE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MYC; RETROELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PRECURSORS; SECRETORY VESICLES; UMBILICAL VEINS;

EID: 79551608032     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1180     Document Type: Article

References (60)

1. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defnes human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
2. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812 (2008).
3. Itadani, H., Mizuarai, S. & Kotani, H. Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation. Curr. Genomics 9, 349-360 (2008).
4. Novakova, J., Slaby, O., Vyzula, R. & Michalek, J. MicroRNA involvement in glioblastoma pathogenesis. Biochem. Biophys. Res. Commun. 386, 1-5 (2009).
5. Kristensen, L. S. & Hansen, L. L. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin. Chem. 55, 1471-1483 (2009).
6. Cadieux, B., Ching, T. T., VandenBerg, S. R. & Costello, J. F. Genome-wide hypomethylation in human glioblastomas associated with specifc copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 66, 8469-8476 (2006).
7. Cowell, J. K. & Lo, K. C Application of oligonucleotides arrays for coincident comparative genomic hybridization, ploidy status and loss of heterozygosity studies in human cancers. Methods Mol. Biol. 556, 47-65 (2009).
8. Skog, J. et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol. 10, 1470-1476 (2008).
9. Taylor, D. D. & Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21 (2008).
10. Tani, E. In Progress in Neuropathology (ed. Zimmerman, H. M.) 129-172 (Grune and Stratton, 1976).
11. Simons, M. & Raposo, G. Exosomes\vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575-581 (2009).
12. Booth, A. M. et al. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell. Biol. 172, 923-935 (2006).
13. Lakkaraju, A. & Rodriguez-Boulan, E. Itinerant exosomes: emerging roles in cell and tissue polarity Trends Cell Biol 18, 199-209 (2008).
14. Halicka, H. D., Bedner, E. & Darzynkiewicz, Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp. Cell. Res. 260, 248-256 (2000).
15. Voisset, C., Weiss, R. A. & Grifths, D. J. Human RNA 'rumor' viruses: the search for novel human retroviruses in chronic disease. Microbiol. Mol. Biol. Rev. 72, 157-196 (2008).
16. Iero, M. et al. Tumour-released exosomes and their implications in cancer immunity Cell Death Difer. 15, 80-88 (2008).
17. Téry C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579 (2002).
18. Guescini, M., Genedani, S., Stocchi, V. & Agnati, L. F. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J. Neural Transm. 117, 1-4 (2010).
19. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9, 654-659 (2007).
20. Baj-Krzyworzeka, M. et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 55, 808-818 (2006).
21. Burghof, S. et al. Horizontal gene transfer from human endothelial cells to rat cardiomyocytes afer intracoronary transplantation. Cardiovasc. Res. 77, 534-543 (2008).
22. Deregibus, M. C. et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110, 2440-2448 (2007).
23. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A. & Ratajczak, M. Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495 (2006).
24. Yuan, A. et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 4, e4722 (2009).
25. Bergsmedh, A. et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl Acad. Sci. USA 98, 6407-6411 (2001).
26. Goodier, J. L. & Kazazian, H. H. J. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 135, 23-35 (2008).
27. Daskalos, A. et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int. J. Cancer 124, 81-87 (2009).
28. Estécio, M. R. et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability PLoS One 2, e399 (2007).
29. Roman-Gomez, J. et al. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk. Res. 32, 487-490 (2008).
30. Cho, N. Y. et al. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J. Pathol. 211, 269-277 (2007).
31. Bratthauer, G. L., Cardif, R. D. & Fanning, T. G. Expression of LINE-1 retrotransposons in human breast cancer. Cancer 73, 2333-2336 (1994).
32. Golan, M. et al. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia 10, 521-533 (2008).
33. Ruprecht, K., Mayer, J., Sauter, M., Roemer, K. & Mueller-Lantzsch, N. Endogenous retroviruses and cancer. Cell. Mol. Life Sci. 65, 3366-3382 (2008).
34. Kleiman, A. et al. HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy efect in patients with germ cell tumors. Int J. Cancer 110, 459-461 (2004).
35. Wang-Johanning, F. et al. Human endogenous retrovirus K triggers an antigen-specifc immune response in breast cancer patients. Cancer Res. 68, 5869-5877 (2008).
36. Contreras-Galindo, R. et al. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J. Virol. 82, 9329-9336 (2008).
37. Bigner, S. H., Friedman, H. S., Vogelstein, B., Oakes, W. J. & Bigner, D. D. Amplifcation of the c-myc gene in human medulloblastoma cell lines and xenografs. Cancer Res. 50, 2347-2350 (1990).
38. Tez, S., Koktener, A., Guler, G. & Ozisik, P. Atypical teratoid/rhabdoid tumors: imaging fnding of two cases and review of the literature. Turk. Neurosurg. 18, 30-34 (2008).
39. Jemal, A. et al. Cancer statistics. CA Cancer J. Clin. 58, 71-96 (2008).
40. Giard, D. J. et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl Cancer Inst. 51, 1417-1423 (1973).
41. Storlazzi, C. T. et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum. Mol. Genet 15, 933-942 (2006).
42. Dudoit, S., Yang, Y H., Callow, M. J. & Speed, T. P. Statistical methods for identifying diferentially expressed genes in replicated cDNA microarray experiments. Stat Sin. 12, 111-140 (2002).
43. Graner, M. W. et al. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 23, 1541-1557 (2009).
44. Al-Nedawi, K. et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 10, 619-624 (2008).
45. Stetson, D. B., Ko, J. S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity Cell 134, 587-598 (2008).
46. Miranda, K. C. et al. (2010). Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 78, 191-199 (2010).
47. Albertson, D. G. Gene amplifcation in cancer. Trends Genet. 22, 447-455 (2006).
48. Shimizu, N. Extrachromosomal double minutes and chromosomal homogeneously staining regions as probes for chromosome research. Cytogenet Genome Res. 124, 312-326 (2009).
49. Blow, J. J. & Gillespie, P. J. Replication licensing and cancer-a fatal entanglement? Nat Rev. Cancer 8, 799-806 (2008).
50. Ahn, K. & Kim, H. S. Structural and quantitative expression analyses of HERV gene family in human tissues. Mol. Cell 28, 99-103 (2009).
51. Singh, S. K. et al. Identifcation of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003).
52. Bannert, N. & Kurth, R. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl Acad. Sci. USA 101, 14572-14579 (2004).
53. Wiemels, J. L. et al. Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally Cancer Res. 68, 9935-9944 (2008).
54. Miki, Y et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52, 643-645 (1992).
55. Morse, B., Rotherg, P. G., South, V. J., Spandorfer, J. M. & Astrin, S. M. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 333, 87-90 (1988).
56. Mangiacasale, R. et al. Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes diferentiation. Oncogene 22, 2750-2761 (2003).
57. Serafno, A. et al. T e activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp. Cell Res. 315, 849-862 (2009).
58. Wallace, N. A., Belancio, V. P. & Deininger, P. L. L1 mobile element expression causes multiple types of toxicity. Gene 419, 75-81 (2008).
59. Pothlichet, J., Mangeney M. & Heidmann, T. Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo. Int J. Cancer 119, 1869-1877 (2006).
60. Siu, I. M., Lal, A., Blankenship, J. R., Aldosari, N. & Riggins, G. J. c-Myc promoter activation in medulloblastoma. Cancer Res. 63, 4773-4776 (2003).